Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126133572 | 12613357 | 2 | F | 2016 | 20160909 | 20160802 | 20160913 | EXP | PL-ROCHE-1740343 | ROCHE | 0.00 | M | Y | 0.00000 | 20160913 | CN | PL | PL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126133572 | 12613357 | 1 | PS | PEGASYS | PEGINTERFERON ALFA-2A | 1 | Unknown | 180MCG/ 0.5ML, RECEIVED 48 ADMINISTRATIONS | U | 103964 | 180 | UG | SOLUTION FOR INJECTION | /wk |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126133572 | 12613357 | 1 | Hepatitis C |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126133572 | 12613357 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126133572 | 12613357 | Eye pain | |
| 126133572 | 12613357 | Hyperthyroidism | |
| 126133572 | 12613357 | Hypothyroidism | |
| 126133572 | 12613357 | Medication error | |
| 126133572 | 12613357 | Thyroid disorder | |
| 126133572 | 12613357 | Visual acuity reduced | |
| 126133572 | 12613357 | Wrong technique in product usage process |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126133572 | 12613357 | 1 | 20150626 | 201605 | 0 |